Searchable abstracts of presentations at key conferences in endocrinology

ea0043oc8 | Cardiovascular Outcome Studies | WCTD2016

Bromocriptine shifts the blood pressure circadian rhythm in type 2 DM and stage 4 of chronic kidney disease patients: A post hoc study

Mejia-Rodriguez Oliva , Ruiz-Vega Humberto , Alvarez-Aguilar Cleto , Ceballos-Reyes Guillermo , Galvan-Plata Maria Eugenia , Paniagua Ramon

Background: Type 2 DM and chronic renal disease CKD are conditions associated with severe hypertension, loss of the blood pressure circadian rhythm (CR) and sympathetic nervous system (SNS) hyperactivity, suggesting a deficient dopaminergic modulation that could be reversed with dopamine agonists such as bromocriptine (BEC).Objective: The objective of this study was to evaluate the effect of bromocriptine in the blood pressure CR in patients with type 2 ...